• About
  • Licensing
  • Podcasting
  • Contact

AudioMedica.com

  • Public Health
  • Oncology
  • Cardiovascular
  • General Medicine

Natalizumab Risks and Benefits in Multiple Sclerosis

  • in General Medicine
  • — 3 Mar, 2006
Natalizumab Risks and Benefits in Multiple Sclerosis
AudioMedica News
Natalizumab Risks and Benefits in Multiple Sclerosis
Natalizumab Risks and Benefits in Multiple Sclerosis
00:00 /
RSS Feed
Share
Link
Embed
//-->//>' class="input-embed input-embed-115"/>

Chris Polman, Free University of Amsterdam
Abstract N Engl J Med 2006;345:899
Despite fears that natalizumab – which reduces progression in some categories of patients with multiple sclerosis – might increased the risk of a fatal viral infection, two-year randomised study finding have now given some reassurance that patients with relapsing disease can be treated.
[audio:https://www.audiomedica.com/podcasting/news/chris_polman.mp3]

You may also like...

  • Tumour Necrosis Factor Up-regulation: Key to Severe Asthma? Tumour Necrosis Factor Up-regulation: Key to Severe Asthma? 23 Feb, 2006
  • Vaginal Progesterone Reduced Risk of Preterm Birth in Women with Short Cervix Vaginal Progesterone Reduced Risk of Preterm Birth in Women with Short Cervix 23 Aug, 2007
  • A middle cerebral artery anueurism: International Subarachnoid Aneurism Trial (ISAT) A middle cerebral artery anueurism: International Subarachnoid Aneurism Trial (ISAT) 27 Sep, 2005
  • Audio Journal of Hematologic Malignancy Special Edition 2005 Audio Journal of Hematologic Malignancy Special Edition 2005 14 Jan, 2006

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

  • Previous story Lytic Therapy Does Not Facilitate PCI
  • Next story Pregnancy Risk from Cervical Excision
  • News

    • Mandeep Mehra MDCOVID-19 Co-Morbidity Risks Quantified from Three Continents SurveyMay 28, 2020
    • Ultrahypofractionated Radiation Just As Effective for Prostate CancerUltrahypofractionated Radiation Just As Effective for Prostate CancerMay 16, 2018
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.First evidence that genome editing made patients with AIDS more resistant to HIVMarch 8, 2014
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.Anticoagulation with warfarin can be beneficial in patients with atrial fibrillation and chronic kidney disease.March 7, 2014
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.Prostate cancer: Adult exposure to bisphenol-A linked to prostate cancer riskMarch 6, 2014
  • Related interviews

    • Ibrutinib: New Frontline Standard for Chronic…
    • New Front Line Standard for Older Patients with…
    • Microbiome Diversity Key To Survival After…
    • Polygenic Risk Scores Could Help Predict Second…
    • Genomic-led AML Clinical Decision Making Within Seven Days
  • Home
  • General Medicine
  • Natalizumab Risks and Benefits in Multiple Sclerosis

© COPYRIGHT 2020 AUDIOMEDICA.COM.